Epigenetic regulation of innate immune dynamics during inflammation
- 1 February 2024
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 115 (4) , 589-606
Abstract
Innate immune cells play essential roles in modulating both immune defense and inflammation by expressing a diverse array of cytokines and inflammatory mediators, phagocytizing pathogens to promote immune clearance, and assisting with the adaptive immune processes through antigen presentation. Rudimentary innate immune “memory” states such as training, tolerance, and exhaustion develop based on the nature, strength, and duration of immune challenge, thereby enabling dynamic transcriptional reprogramming to alter present and future cell behavior. Underlying transcriptional reprogramming are broad changes to the epigenome, or chromatin alterations above the level of DNA sequence. These changes include direct modification of DNA through cytosine methylation as well as indirect modifications through alterations to histones that comprise the protein core of nucleosomes. In this review, we will discuss recent advances in our understanding of how these epigenetic changes influence the dynamic behavior of the innate immune system during both acute and chronic inflammation, as well as how stable changes to the epigenome result in long-term alterations of innate cell behavior related to pathophysiology.Keywords
This publication has 229 references indexed in Scilit:
- 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytesGenome Biology, 2013
- Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized DerivativesCell, 2013
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Plasmodium falciparum Histones Induce Endothelial Proinflammatory Response and Barrier DysfunctionThe American Journal of Pathology, 2012
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Conserved role of intragenic DNA methylation in regulating alternative promotersNature, 2010
- Jmjd3 contributes to the control of gene expression in LPS‐activated macrophagesThe EMBO Journal, 2009
- Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosaMicrobes and Infection, 2008
- The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene SilencingCell, 2007